Compare SBLK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SBLK | HAE |
|---|---|---|
| Founded | 2006 | 1971 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.8B |
| IPO Year | 2007 | 1996 |
| Metric | SBLK | HAE |
|---|---|---|
| Price | $27.15 | $67.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $25.50 | ★ $84.13 |
| AVG Volume (30 Days) | ★ 1.3M | 850.0K |
| Earning Date | 05-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.33% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.05 |
| Revenue | N/A | ★ $910,373,000.00 |
| Revenue This Year | $11.56 | N/A |
| Revenue Next Year | N/A | $5.23 |
| P/E Ratio | $47.06 | ★ $32.92 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.84 | $47.32 |
| 52 Week High | $28.28 | $87.32 |
| Indicator | SBLK | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 60.53 | 70.34 |
| Support Level | $25.90 | $49.26 |
| Resistance Level | $27.45 | $86.72 |
| Average True Range (ATR) | 0.77 | 2.94 |
| MACD | -0.01 | 1.42 |
| Stochastic Oscillator | 52.31 | 93.45 |
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. The firm generates the majority of its revenue from Time charters and Voyage charters.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.